POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding POINT Biopharma Global Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 106 | 109 | +3 |
| Shares | 60.9M | 61.1M | +257.4K (+0.4%) |
| Value | $470.4M | $445.5M | −$24.9M (−5.3%) |
New holders (20)
Institutions that held POINT Biopharma Global Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 1,827,304 | $13.3M | 0.58% |
| Gluskin Sheff & Assoc Inc | 762,905 | $5.56M | 0.31% |
| Velan Capital Investment Management LP | 494,136 | $3.60M | 3.83% |
| Vontobel Holding Ltd. | 197,278 | $1.44M | 0.01% |
| Sectoral Asset Management Inc | 185,278 | $1.35M | 0.26% |
| Cheyne Capital Management (UK) LLP | 127,090 | $926.5K | 1.63% |
| Jane Street Group, LLC | 28,744 | $209.5K | 0.00% |
| Two Sigma Investments, LP | 24,600 | $179.3K | 0.00% |
| Corton Capital Inc. | 15,268 | $111.3K | 0.09% |
| Delphia (USA) Inc. | 14,027 | $102.3K | 0.12% |
| Janus Henderson Group PLC | 13,938 | $101.5K | 0.00% |
| Jump Financial, LLC | 13,646 | $99.5K | 0.01% |
| Portland Investment Counsel Inc. | 13,600 | $99.0K | 0.06% |
| Bridgefront Capital, LLC | 12,829 | $93.5K | 0.07% |
| ProShare Advisors LLC | 10,999 | $80.2K | 0.00% |
| AQR Capital Management LLC | 10,615 | $77.4K | 0.00% |
| Aquatic Capital Management LLC | 8,100 | $59.0K | 0.00% |
| Amundi | 5,829 | $42.3K | 0.00% |
| FinTrust Capital Advisors, LLC | 1,000 | $7.29K | 0.00% |
| Mendota Financial Group, LLC | 1 | $7 | 0.00% |
Sold out (17)
Institutions that held POINT Biopharma Global Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Fairmount Funds Management LLC | 2,833,950 | $21.9M |
| Balyasny Asset Management LLC | 1,322,508 | $10.2M |
| Deerfield Management Company, L.P. (Series C) | 1,000,000 | $7.73M |
| Sio Capital Management, LLC | 544,545 | $4.21M |
| Eversept Partners, LP | 410,052 | $3.17M |
| Alyeska Investment Group, L.P. | 346,171 | $2.68M |
| Walleye Capital LLC | 131,260 | $1.01M |
| Marshall Wace, LLP | 115,102 | $890.0K |
| BNP Paribas Arbitrage, SA | 69,078 | $534.0K |
| HighVista Strategies LLC | 43,836 | $339.0K |
| Occudo Quantitative Strategies LP | 16,615 | $128.0K |
| Bayesian Capital Management, LP | 14,962 | $116.0K |
| Ensign Peak Advisors, Inc | 13,600 | $105.0K |
| Tudor Investment Corp Et Al | 10,282 | $79.0K |
| Leonteq Securities AG | 9,000 | $69.6K |
| Psagot Value Holdings Ltd. / (Israel) | 4,000 | $31.0K |
| Federated Hermes, Inc. | 308 | $2.00K |